Skip to main content
Download PDF
- Main
From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research
Published Web Location
https://doi.org/10.1038/s42255-024-00985-1Abstract
Non-alcoholic liver disease (NAFLD) is now metabolic dysfunction-associated steatotic liver disease (MASLD), emphasizing the key metabolic factors of obesity, insulin resistance, vascular dysfunction, and dyslipidemia. Here, we discuss impacts on the existing body of clinical and preclinical liver disease research and research moving forward.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
For improved accessibility of PDF content, download the file to your device.
Enter the password to open this PDF file:
File name:
-
File size:
-
Title:
-
Author:
-
Subject:
-
Keywords:
-
Creation Date:
-
Modification Date:
-
Creator:
-
PDF Producer:
-
PDF Version:
-
Page Count:
-
Page Size:
-
Fast Web View:
-
Preparing document for printing…
0%